To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.
This is a protocol.
Capecitabine for ER-positive versus ER-negative breast cancer
You may also be interested in:
- Taxane chemotherapy before or after anthracycline chemotherapy in early breast cancer
- High-dose chemotherapy and bone marrow or stem cell transplantation for early poor prognosis breast cancer using a woman's own cells (autologous)
- Taxane-containing chemotherapy for women after surgery for early breast cancer
- Sequencing of chemotherapy and radiotherapy for women following surgery for early breast cancer
- Cyclin-dependent kinase (CDK) inhibitors for hormone receptor-positive advanced breast cancer
Health topics: